We are live on ! Find out more
IPC

Independent Portfolio Consultants Portfolio holdings

AUM $241M
1-Year Est. Return 21.8%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+21.8%
3 Year Est. Return
+32.36%
5 Year Est. Return
10 Year Est. Return
AUM
$286M
AUM Growth
+$36.4M
Cap. Flow
+$16.3M
Cap. Flow %
5.7%
Top 10 Hldgs %
8.52%
Holding
484
New
50
Increased
192
Reduced
195
Closed
41

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$944K
2
ALKS icon
Alkermes
ALKS
+$790K
3
ORA icon
Ormat Technologies
ORA
+$784K
4
GILD icon
Gilead Sciences
GILD
+$757K
5
AMAT icon
Applied Materials
AMAT
+$756K

Sector Composition

Rank Sector Weight
1 Industrials 17.34%
2 Financials 12.59%
3 Technology 12.24%
4 Healthcare 10.85%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRN icon
1
Trinity Industries
TRN
$2.33B
$2.96M 1.03%
150,932
+45,490
+43% +$825K
CBI
2
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.75M 0.96%
33,069
+13,990
+73% +$1.06M
WU icon
3
Western Union
WU
$2.26B
$2.73M 0.95%
158,042
+48,041
+44% +$842K
FLS icon
4
Flowserve
FLS
$10.2B
$2.53M 0.88%
32,059
+10,615
+50% +$736K
IEX icon
5
IDEX
IEX
$17B
$2.44M 0.85%
33,091
+9,625
+41% +$669K
AAPL icon
6
Apple
AAPL
$4.67T
$2.4M 0.84%
120,008
+21,980
+22% +$415K
NVS icon
7
Novartis
NVS
$292B
$2.2M 0.77%
30,486
+2,773
+10% +$193K
DAR icon
8
Darling Ingredients
DAR
$10.1B
$2.15M 0.75%
102,770
+49,636
+93% +$1.06M
HBI
9
DELISTED
Hanesbrands
HBI
$2.13M 0.74%
120,940
+44,460
+58% +$740K
BR icon
10
Broadridge
BR
$20.9B
$2.11M 0.74%
53,446
+7,540
+16% +$272K
GSK icon
11
GSK
GSK
$102B
$2.06M 0.72%
30,929
+2,908
+10% +$189K
URS
12
DELISTED
URS CORP
URS
$2.06M 0.72%
38,825
+12,435
+47% +$655K
ORCL icon
13
Oracle
ORCL
$435B
$2.02M 0.71%
52,749
+5,537
+12% +$190K
AGCO icon
14
AGCO
AGCO
$7.94B
$1.97M 0.69%
33,306
+10,450
+46% +$623K
TTE icon
15
TotalEnergies
TTE
$191B
$1.93M 0.67%
31,492
+355
+1% +$21.1K
NFX
16
DELISTED
Newfield Exploration
NFX
$1.88M 0.66%
76,201
+27,030
+55% +$758K
CLH icon
17
Clean Harbors
CLH
$16.4B
$1.87M 0.65%
31,225
+16,495
+112% +$951K
TDW icon
18
Tidewater
TDW
$4.61B
$1.86M 0.65%
971
+283
+41% +$538K
SNY icon
19
Sanofi
SNY
$107B
$1.84M 0.64%
34,240
+1,485
+5% +$76.6K
PNR icon
20
Pentair
PNR
$9.84B
$1.83M 0.64%
35,142
+12,031
+52% +$559K
CNC icon
21
Centene
CNC
$32B
$1.76M 0.62%
119,672
+15,600
+15% +$233K
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.75M 0.61%
23,348
+1,855
+9% +$131K
MWV
23
DELISTED
MEADWESTVACO CORP
MWV
$1.74M 0.61%
47,092
+15,910
+51% +$574K
GE icon
24
GE Aerospace
GE
$355B
$1.73M 0.6%
12,863
+1,518
+13% +$191K
PII icon
25
Polaris
PII
$3.63B
$1.58M 0.55%
10,821
+3,795
+54% +$508K

Similar funds

Independent Portfolio Consultants's Q4 2013 Portfolio in Review

As of Q4 2013, Independent Portfolio Consultants held 484 positions worth $286M, up 15% from $250M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Independent Portfolio Consultants deployed $16.3M of net new capital in Q4 2013, opening 50 new positions and adding to 192 existing holdings. Its largest new stake was Antero Resources: 13,995 shares worth $888K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $757K trimmed.

  • Independent Portfolio Consultants's largest Q4 2013 buy was Antero Resources: 13,995 shares worth $888K.
  • Independent Portfolio Consultants added most to Manhattan Associates in Q4 2013, an estimated $1.35M increase.
  • Independent Portfolio Consultants's biggest Q4 2013 reduction was Gilead Sciences, cutting an estimated $757K.
  • Independent Portfolio Consultants fully exited Akamai in Q4 2013, selling an estimated $944K.
  • Independent Portfolio Consultants's ten largest holdings make up 8.5% of its $286M portfolio in Q4 2013.
  • Independent Portfolio Consultants opened 50 new positions and closed 41 in Q4 2013.
  • Independent Portfolio Consultants's portfolio value rose 15% quarter-over-quarter to $286M.

Based on Independent Portfolio Consultants's 13F filing for Q4 2013, filed 29 Jan 2014.